Literature DB >> 32341108

Telomere length in patients with unclassifiable interstitial lung disease: a cohort study.

Brett Ley1,2, Shuo Liu3, Brett M Elicker4, Travis S Henry4, Eric Vittinghoff5, Jeffrey A Golden3, Kirk D Jones6, Paul J Wolters3.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32341108     DOI： 10.1183/13993003.00268-2020

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  5 in total

1.  Family History of Pulmonary Fibrosis Predicts Worse Survival in Patients With Interstitial Lung Disease.

Authors:  Claire C Cutting; Willis S Bowman; Nam Dao; Janelle Vu Pugashetti; Christine Kim Garcia; Justin M Oldham; Chad A Newton
Journal:  Chest       Date:  2021-01-21       Impact factor: 9.410

Review 2.  Progression in the Management of Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases, Where Are We Now and Where We Would Like to Be.

Authors:  Tinne Goos; Laurens J De Sadeleer; Jonas Yserbyt; Geert M Verleden; Marie Vermant; Stijn E Verleden; Wim A Wuyts
Journal:  J Clin Med       Date:  2021-03-23       Impact factor: 4.241

Review 3.  Familial Pulmonary Fibrosis: Genetic Features and Clinical Implications.

Authors:  David Zhang; Chad A Newton
Journal:  Chest       Date:  2021-06-26       Impact factor: 9.410

4.  Peripheral blood leucocyte telomere length is associated with progression of interstitial lung disease in systemic sclerosis.

Authors:  Shuo Liu; Melody P Chung; Brett Ley; Sarah French; Brett M Elicker; David F Fiorentino; Lorinda S Chung; Francesco Boin; Paul J Wolters
Journal:  Thorax       Date:  2021-07-16       Impact factor: 9.102

Review 5.  Telomeres in Interstitial Lung Disease.

Authors:  Carmel J W Stock; Elisabetta A Renzoni
Journal:  J Clin Med       Date:  2021-03-30       Impact factor: 4.241
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.